SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-008397
Filing Date
2023-02-06
Accepted
2023-02-06 14:45:25
Documents
1
Group Members
HOPEWELL RESOURCES HOLDINGS LTDLAV AQUA LTDORIENTAL SPRING VENTURE LTDYI SHI

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea172755-13ga2lavbio5_terns.htm SC 13G/A 148597
  Complete submission text file 0001213900-23-008397.txt   150348
Mailing Address C/O ESTERA TRUST (CAYMAN) LIMITED 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108
Business Address C/O ESTERA TRUST (CAYMAN) LIMITED 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108 345-640-0540
LAV Biosciences Fund V, L.P. (Filed by) CIK: 0001764435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Subject) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92116 | Film No.: 23590037
SIC: 2834 Pharmaceutical Preparations